materials-logo

Journal Browser

Journal Browser

Self-Assembled Block Copolymers for Drug Delivery

A special issue of Materials (ISSN 1996-1944). This special issue belongs to the section "Advanced Nanomaterials and Nanotechnology".

Deadline for manuscript submissions: closed (20 June 2023) | Viewed by 794

Special Issue Editor


E-Mail Website
Guest Editor
Department of Biopharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, Poland
Interests: tissue engineering; nanotechnology; drug carriers; cell culture; molecular biology

Special Issue Information

Dear Colleagues,

Nanoparticle-based drug carriers are expected to overcome several limitations associated with conventional dosage forms. Their capabilities to cope with such problems as low drug bioavailability, nonspecific distribution, systemic side effects, low water solubility, rapid biotransformation, or degradation are a powerful driving force for nanopharmacy development. Especially, cancer therapy is a field where significant progress in the research on nanoparticle carriers has been achieved. After intravenous injection, nanoparticles can accumulate preferentially in the tumor tissue due to passive targeting, as a consequence of its leaky vasculature (enhanced permeability and retention effect, EPR). Active targeting is achieved by means of decorating the nanoparticle surface with ligands recognizing appropriate structures on target cells. Among numerous types of nanoparticles, aggregates made of amphiphilic block copolymers show great potential as drug carriers. Amphiphilic molecules in water solution can associate into various structures, such as micelles, filomicelles, and vesicles. Polymeric aggregates typically have some advantages over aggregates made of low-molecular-weight detergents (e.g., high stability). This Special Issue is open to the recent developments in the application of self-assembled block copolymers for drug delivery. Topics can include, but are not limited to:

  • Multifunctional and multitargeted nanoparticles;
  • New targeting agents for drug carriers;
  • Carriers for multidrug delivery and combination therapy;
  • Stimuli-responsive drug release;
  • Self-assembled nanoparticles with biological polymers;
  • Strategies to enhance stability polymeric micelles.

Dr. Arkadiusz Orchel
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Materials is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • micelles
  • polymersomes
  • drug delivery
  • block copolymers
  • passive targeting
  • active targeting
  • cancer
  • multifunctional nanoparticles
  • EPR effect
  • stimuli-responsive drug release
  • targeting ligand
  • combination therapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop